PAREA in discussion with the EMCDDA about psychedelics for medical use
PAREA met with Alexis Goosdeel, Director of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and his four colleagues. EMCDDA plays an important role in terms of providing evidence-based information to policymakers. To that end, PAREA was informed that the agency is currently working on a project to facilitate a greater understanding of the developments in the area of psychedelic substances for medical use.
A related publication is expected around April next year.